OUR LADY OF LOURDES MEMORIAL HOSP
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.2M
- Transactions
- 195
- Companies
- 22
- Average per transaction
- $5,936
Who reported the payments
| Genentech, Inc. | $1,032,306 |
| Bard Peripheral Vascular, Inc. | $35,269 |
| Smith+Nephew | $31,793 |
| Linvatec Corporation | $14,587 |
| Astrazeneca UK Limited | $14,374 |
| Medtronic | $8,195 |
| Stryker | $6,964 |
| Merge Healthcare Incorporated | $5,610 |
| KARL Storz Endoscopy-america | $3,150 |
| Aesculap, Inc. | $1,797 |
| Baxter Healthcare | $941 |
| Organon | $700 |
| Lilly USA, LLC | $475 |
| AstraZeneca | $300 |
| Vero Biotech Inc. | $216 |
| Zimmer Biomet | $161 |
| Merck | $150 |
| Sanofi-aventis U.S. LLC | $150 |
| Johnson & Johnson | $150 |
| Boehringer Ingelheim | $150 |
| Qiagen, LLC | $108 |
| Bio-rad Laboratories, Inc. | $40 |